As a financial analyst, you have just been handed the 2012 financial report of Firm A, a large, global pharmaceutical company. Firm A competes in both traditional pharmaceutical products and in evolving biotechnology products. The following data (in billions) on Firm A and the pharmaceutical industry are available.
Firm A Industry Average
Sales $2.00 $0.960
Net income 0.54 0.096
Advertising 0.04 0.160
Research and development 0.16 0.240
New investment in facilities 0.20 0.240
Given these data, evaluate the cost management performance of Firm A.